acute myeloid leukemia, AML
Conditions
Interventions
ultra-sensitive mutation burden(UMB)-positive group:None
ultra-sensitive mutation burden(UMB)-negative group:None
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years; 2. Complies with the diagnostic criteria for AML as stipulated in the WHO 2016 edition; 3. Expected survival time >= 3 months; 4. The samples are available and meet the research requirements, and the clinical data are complete.
Exclusion criteria
Exclusion criteria: 1.Diagnosed with acute promyelocytic leukemia; 2.Combine other active and uncontrolled malignant tumors; 3.HIV infection; 4.Patients with central nervous system involvement; 5.The researchers determined that certain patients were not suitable for participating in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cumulative incidence of relapse, CIR; | — |
Secondary
| Measure | Time frame |
|---|---|
| event-free survival, EFS;overall survival, OS; | — |
Countries
China
Contacts
Public ContactHui Liu
Beijing Hospital
Outcome results
None listed